Compare HOLX & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOLX | EVR |
|---|---|---|
| Founded | 1985 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 14.4B |
| IPO Year | 1990 | 2006 |
| Metric | HOLX | EVR |
|---|---|---|
| Price | $74.92 | $350.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $77.89 | ★ $341.78 |
| AVG Volume (30 Days) | ★ 2.3M | 352.4K |
| Earning Date | 01-29-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 61.11 |
| EPS | 2.40 | ★ 12.55 |
| Revenue | ★ $4,126,500,000.00 | $3,542,875,000.00 |
| Revenue This Year | $6.74 | $24.79 |
| Revenue Next Year | $5.48 | $17.67 |
| P/E Ratio | $31.18 | ★ $28.15 |
| Revenue Growth | 2.17 | ★ 27.03 |
| 52 Week Low | $51.90 | $148.63 |
| 52 Week High | $75.36 | $388.71 |
| Indicator | HOLX | EVR |
|---|---|---|
| Relative Strength Index (RSI) | 49.09 | 45.67 |
| Support Level | $72.28 | $360.82 |
| Resistance Level | $75.36 | $371.33 |
| Average True Range (ATR) | 0.41 | 12.01 |
| MACD | -0.03 | -3.32 |
| Stochastic Oscillator | 84.42 | 8.28 |
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.